vs
Side-by-side financial comparison of CARRIAGE SERVICES INC (CSV) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $105.5M, roughly 1.8× CARRIAGE SERVICES INC). CARRIAGE SERVICES INC runs the higher net margin — 11.6% vs 0.9%, a 10.7% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 8.0%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $6.2M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 1.0%).
Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
CSV vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $105.5M | $185.2M |
| Net Profit | $12.3M | $1.7M |
| Gross Margin | 34.8% | 85.7% |
| Operating Margin | 23.3% | 8.6% |
| Net Margin | 11.6% | 0.9% |
| Revenue YoY | 8.0% | 23.7% |
| Net Profit YoY | 24.5% | -88.5% |
| EPS (diluted) | $0.76 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $105.5M | $185.2M | ||
| Q3 25 | $102.7M | $169.1M | ||
| Q2 25 | $102.1M | $154.7M | ||
| Q1 25 | $107.1M | $125.2M | ||
| Q4 24 | $97.7M | $149.7M | ||
| Q3 24 | $100.7M | $141.5M | ||
| Q2 24 | $102.3M | $126.7M | ||
| Q1 24 | $103.5M | $110.4M |
| Q4 25 | $12.3M | $1.7M | ||
| Q3 25 | $6.6M | $17.3M | ||
| Q2 25 | $11.7M | $-24.4M | ||
| Q1 25 | $20.9M | $-21.7M | ||
| Q4 24 | $9.9M | $14.7M | ||
| Q3 24 | $9.9M | $-6.7M | ||
| Q2 24 | $6.3M | $-15.7M | ||
| Q1 24 | $7.0M | $-48.4M |
| Q4 25 | 34.8% | 85.7% | ||
| Q3 25 | 35.3% | 88.5% | ||
| Q2 25 | 35.2% | 90.2% | ||
| Q1 25 | 35.3% | 90.7% | ||
| Q4 24 | 34.4% | 90.1% | ||
| Q3 24 | 35.2% | 90.6% | ||
| Q2 24 | 36.2% | 91.1% | ||
| Q1 24 | 36.0% | 87.7% |
| Q4 25 | 23.3% | 8.6% | ||
| Q3 25 | 17.0% | 20.3% | ||
| Q2 25 | 23.5% | -6.1% | ||
| Q1 25 | 29.5% | -6.3% | ||
| Q4 24 | 21.6% | 10.7% | ||
| Q3 24 | 22.7% | 15.3% | ||
| Q2 24 | 18.0% | 11.8% | ||
| Q1 24 | 18.8% | -25.1% |
| Q4 25 | 11.6% | 0.9% | ||
| Q3 25 | 6.4% | 10.2% | ||
| Q2 25 | 11.5% | -15.8% | ||
| Q1 25 | 19.5% | -17.3% | ||
| Q4 24 | 10.1% | 9.8% | ||
| Q3 24 | 9.8% | -4.8% | ||
| Q2 24 | 6.1% | -12.4% | ||
| Q1 24 | 6.7% | -43.9% |
| Q4 25 | $0.76 | $0.00 | ||
| Q3 25 | $0.41 | $0.06 | ||
| Q2 25 | $0.74 | $-0.08 | ||
| Q1 25 | $1.34 | $-0.07 | ||
| Q4 24 | $0.62 | $0.05 | ||
| Q3 24 | $0.63 | $-0.02 | ||
| Q2 24 | $0.40 | $-0.05 | ||
| Q1 24 | $0.45 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $254.8M | $274.2M |
| Total Assets | $1.3B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $293.5M | ||
| Q3 25 | $1.2M | $263.8M | ||
| Q2 25 | $1.4M | $231.0M | ||
| Q1 25 | $4.6M | $250.6M | ||
| Q4 24 | $1.2M | $249.9M | ||
| Q3 24 | $1.3M | $249.8M | ||
| Q2 24 | $1.5M | $260.1M | ||
| Q1 24 | $1.7M | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $254.8M | $274.2M | ||
| Q3 25 | $242.1M | $230.4M | ||
| Q2 25 | $235.4M | $204.3M | ||
| Q1 25 | $223.1M | $193.6M | ||
| Q4 24 | $208.6M | $194.0M | ||
| Q3 24 | $198.1M | $178.8M | ||
| Q2 24 | $187.9M | $132.5M | ||
| Q1 24 | $179.6M | $130.7M |
| Q4 25 | $1.3B | $949.9M | ||
| Q3 25 | $1.3B | $868.8M | ||
| Q2 25 | $1.3B | $815.3M | ||
| Q1 25 | $1.3B | $789.8M | ||
| Q4 24 | $1.3B | $785.0M | ||
| Q3 24 | $1.3B | $786.6M | ||
| Q2 24 | $1.3B | $749.5M | ||
| Q1 24 | $1.3B | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.1M | $16.3M |
| Free Cash FlowOCF − Capex | $6.2M | $16.0M |
| FCF MarginFCF / Revenue | 5.9% | 8.6% |
| Capex IntensityCapex / Revenue | 7.5% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.15× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.1M | $16.3M | ||
| Q3 25 | $24.7M | $35.7M | ||
| Q2 25 | $8.1M | $-26.5M | ||
| Q1 25 | $13.8M | $7.8M | ||
| Q4 24 | $9.3M | $-3.9M | ||
| Q3 24 | $20.9M | $-23.0M | ||
| Q2 24 | $2.2M | $22.7M | ||
| Q1 24 | $19.7M | $-29.7M |
| Q4 25 | $6.2M | $16.0M | ||
| Q3 25 | $18.0M | $35.3M | ||
| Q2 25 | $5.2M | $-28.9M | ||
| Q1 25 | $10.6M | $7.5M | ||
| Q4 24 | $4.9M | $-4.2M | ||
| Q3 24 | $16.2M | $-23.3M | ||
| Q2 24 | $-1.4M | $21.6M | ||
| Q1 24 | $16.2M | $-31.5M |
| Q4 25 | 5.9% | 8.6% | ||
| Q3 25 | 17.5% | 20.9% | ||
| Q2 25 | 5.1% | -18.7% | ||
| Q1 25 | 9.9% | 6.0% | ||
| Q4 24 | 5.0% | -2.8% | ||
| Q3 24 | 16.1% | -16.5% | ||
| Q2 24 | -1.4% | 17.0% | ||
| Q1 24 | 15.6% | -28.5% |
| Q4 25 | 7.5% | 0.2% | ||
| Q3 25 | 6.5% | 0.2% | ||
| Q2 25 | 2.8% | 1.6% | ||
| Q1 25 | 3.0% | 0.2% | ||
| Q4 24 | 4.5% | 0.2% | ||
| Q3 24 | 4.6% | 0.3% | ||
| Q2 24 | 3.5% | 0.9% | ||
| Q1 24 | 3.4% | 1.6% |
| Q4 25 | 1.15× | 9.62× | ||
| Q3 25 | 3.76× | 2.06× | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.94× | -0.27× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 2.83× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
